Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ALZN is expected to report earnings to -67 cents per share on September 15
Q3'26
Est.
$-0.67
Q2'26
Missed
by $0.25
Q1'26
Missed
by $0.16
Q4'25
Beat
by $0.31
Q3'25
Missed
by $0.66
The last earnings report on July 01 showed earnings per share of -67 cents, missing the estimate of -41 cents. With 30.01K shares outstanding, the current market capitalization sits at 4.41M.